Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Gamma-aminobutyric Acid (GABA) Receptor Agonist Market will grow at a CAGR of 8% during the forecast period of 2022 to 2028.

Gammaaminobutyric acid (GABA) receptor agonist drugs are a class of sedatives that mimic the activity of a neurotransmitter receptor known as the gamma-aminobutyric acid (GABA) receptor found in the brain of mammals. They are used to treat various CNS disorders.

Market Segments

By Indication

• Insomnia
• Epilepsy
• Spasticity
• Anxiety

By Drugs

• Zolpidem
• Topiramate
• Baclofen

By Therapeutics

• Bamaluzole
• Phenibut
• Baclofen
• Gaboxadol

Key Players

Some of the major players operating in the gamma-aminobutyric acid (GABA) receptor agonist market are Sanofi, Mylan N.V., Teva Pharmaceutical Industries Ltd, Novartis AG, Aytu BioScience, Inc., Dr. Reddy’s Laboratories Ltd, Endo Pharmaceuticals Inc., Lupin, Johnson & Johnson Services, Inc, Lannett, Sun Pharmaceutical Industries Ltd, Cipla Inc, Aurobindo Pharma and Zydus Cadila among others.

Scope of the Report

The research study analyzes the global Gamma-aminobutyric Acid (GABA) Receptor Agonist industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Report

1. What was the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Gamma-aminobutyric Acid (GABA) Receptor Agonist Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Gamma-aminobutyric Acid (GABA) Receptor Agonist Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.